Home
SAB Biotherapeutics

SAB Biotherapeutics Market Share Analysis for June 2026

SIOUX FALLS, S.D.--(BUSINESS WIRE)--SAB Biotherapeutics (SAB), a clinical-stage biopharmaceutical company with a novel immunotherapy platform that produces specifically targeted, high-potency, fully-human polyclonal antibody therapeutics, today announced that Eddie J. Sullivan, PhD, co-founder, president and CEO, will present at the Ladenburg Thalmann Annual Healthcare Conference on Tuesday, July 13 at 5:00 p.m. ET.

Industry: N/A

Domainsabbiotherapeutics.com

Year Founded2014

Employees51 - 200

Annual Revenue$25M - $50M

SAB Biotherapeutics

SAB Biotherapeutics (including company regionals)

sabbiotherapeutics.com

See more website traffic and engagement information

SAB Biotherapeutics Revenue up to June 2026 is 25M - 50M

revenue generated by SAB Biotherapeutics top domains

SAB Biotherapeutics top domains revenue over 3 years

Revenue for SAB Biotherapeutics top domains

sabbiotherapeutics.com25M - 50M

See more with Sales Intelligence

Total visits to SAB Biotherapeutics's top domains

Understand SAB Biotherapeutics market share and potential market reach.

Total visits last 3 months

No Data to Display

Avg. visit duration in SAB Biotherapeutics's top domains

Analyze SAB Biotherapeutics engagement metrics.

Average visit duration last 3 months

No Data to Display

Avg. pageviews on SAB Biotherapeutics's top domains

See how SAB Biotherapeutics keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

No Data to Display

SAB Biotherapeutics top competitors by domain

Looks like there’s not enough data here

No Data to Display

Top technologies used by SAB Biotherapeutics

These are the website technologies, by industry, used by SAB Biotherapeutics top domains

Content Management System (2)

WordPress

Mobile (2)

Meta Viewport

Widget (2)

Google Maps

Advertising (1)

PubMatic

More Technologies

6

See all

News & Signals from SAB Biotherapeutics

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsSAB Biotherapeutics, Inc. will attend event 2026 Scientific Sessions on Jun 5th '26.SAB BIO will present an oral presentation at the 2026 Scientific Sessions of the American Diabetes Association(R)(ADA) being held June 5-8, 2026, in New Orleans, LA.

NewsSAB Biotherapeutics, Inc. attends event Guggenheim Securities Emerging Outlook: Biotech Summit.SAB Biotherapeutics (Nasdaq: SABS) announced that management will participate in two investor conferences in February 2026: Guggenheim Securities Emerging Outlook: Biotech Summit on February 11, 2026 (10:30 a.m. ET, New York) and Oppenheimer 36th Annual Healthcare Life Sciences Conference on February 25, 2026 (8:40 a.m. ET, virtual).

NewsSAB Biotherapeutics, Inc. attends event International Society for Pediatric and Adolescent Diabetes Annual Conference.SAB BIO to present data at the International Society for Pediatric and Adolescent Diabetes Annual Conference showcasing progress in the development of SAB-142.